Aid workers recover after experimental ebola drug

Hopes of finding a treatment for the deadly ebola virus have shifted to a small California-based biotech company whose experimental drug has been used to treat two American missionary workers.

Aid workers recover after experimental ebola drug

The drug, developed by Mapp Biopharmaceutical Inc, was used to treat the aid workers who were exposed to the disease in Liberia.

Dr Kent Brantly, of Samaritan’s Purse returned to the a US a week ago and his colleague Nancy Writebol of SIM USA flew back via medical aircraft on Tuesday.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited